Article Details
Retrieved on: 2021-07-01 01:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NeuroScientific Biopharmaceuticals' CEO Matt Liddlelow said the results were pleasing. “These positive results, combined with all non-clinical safety ...
Article found on: stockhead.com.au
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here